The company aims to develop, license, market, and apply products, technologies, and services in the fields of health, prevention, diagnostics, and digital medicine. It promotes the establishment and operation of data-based health systems that make the connection between biological, metabolic, and behavioral factors visible and controllable. The company develops, produces, or licenses solutions in the areas of Digital Health, preventive medicine, biomarker diagnostics, wearables, artificial intelligence, biofeedback, microbiome and metabolism analysis, genetics, epigenetics, personalized medicine, and nutrition technology. In addition, it offers consulting, analysis, and development services to companies, healthcare institutions, insurance companies, research institutions, and governments. It can enter into clinical partnerships, accompany studies, and implement educational programs in the field of health and technology. The company can acquire, hold, license, or dispose of products, brands, and technologies, invest in other companies at home and abroad, found subsidiaries, and develop or exploit intangible rights such as patents, databases, or software platforms. It can conduct all transactions that are directly or indirectly related to its purpose or promote it, particularly in the field of metabolic health, digital diagnostics, prevention, and data-driven health innovations. The company can establish branches and subsidiaries at home and abroad and invest in other companies at home and abroad. The company can acquire, encumber, dispose of, and manage real estate at home and abroad. It can also arrange financing on its own account or on behalf of others and provide security for the liabilities of affiliated companies.
Outbound Leads by COHAGA